Trump issues expansive order aimed at lowering drug prices

President Trump's sweeping new executive order, which targets prescription drug pricing, is being met with skepticism and pushback.

President Trump's sweeping new executive order, which targets prescription drug pricing, is being met with skepticism and pushback. The edict released Sunday would compel Medicare to pay the same price for prescription drugs—whether administered in doctors' offices or sold at pharmacies—that they sell for in Europe and other developed countries, where prices generally are more affordable. "It is unacceptable that Americans pay more for the exact same drugs, often made in the exact same places," the order says. "Other countries' governments regulate drug prices by negotiating with drug manufacturers to secure bargain prices, leaving Americans to make up the difference—effectively subsidizing innovation and lower-cost drugs for the rest of the world." The plan replaces another executive order Trump issued in July, which was limited to chemotherapy and other therapies administered in doctors' offices, but an August 24 deadline passed without action. Some watchers doubt the White House's power to put the new order into effect, and the pharmaceutical industry is firmly set against the plan. Lawmakers from the president's own party also are wary, warning that adopting drug prices from nations where government dictates prices is tantamount to importing socialism.